Aberrant expression of calpain family members has been implicated in tumour progression in a number of cancers and expression of calpain-1 and calpain-2 in breast cancer has been shown to be important in patient prognosis [2, 3]. This evidence concerns the gene CAPN1 and breast carcinoma.